GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,351,000 | +90.0% | 6,225 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $711,000 | +16.6% | 6,225 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $610,000 | -81.7% | 6,225 | -77.1% | 0.00% | -83.3% |
| Q2 2020 | $3,341,000 | +42.0% | 27,225 | 0.0% | 0.01% | +20.0% |
| Q1 2020 | $2,353,000 | -17.4% | 27,225 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $2,850,000 | -54.5% | 27,225 | -50.0% | 0.01% | -58.3% |
| Q3 2019 | $6,263,000 | -33.3% | 54,449 | 0.0% | 0.01% | -33.3% |
| Q2 2019 | $9,386,000 | +80.5% | 54,449 | +2.0% | 0.02% | +80.0% |
| Q4 2018 | $5,199,000 | -44.7% | 53,388 | -1.9% | 0.01% | -33.3% |
| Q3 2018 | $9,406,000 | +23.8% | 54,449 | 0.0% | 0.02% | +7.1% |
| Q2 2018 | $7,598,000 | +147.7% | 54,449 | +100.0% | 0.01% | +180.0% |
| Q1 2018 | $3,067,000 | -57.3% | 27,225 | -50.0% | 0.01% | -50.0% |
| Q4 2017 | $7,188,000 | +3080.5% | 54,449 | +2347.1% | 0.01% | – |
| Q3 2017 | $226,000 | -91.7% | 2,225 | -91.8% | 0.00% | -100.0% |
| Q2 2017 | $2,729,000 | -17.1% | 27,225 | 0.0% | 0.01% | -28.6% |
| Q1 2017 | $3,293,000 | +8.2% | 27,225 | -0.0% | 0.01% | 0.0% |
| Q4 2016 | $3,043,000 | +660.8% | 27,229 | +521.7% | 0.01% | +600.0% |
| Q3 2015 | $400,000 | – | 4,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|